Stock KLY KALYTERA THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Kalytera Therapeutics Inc Toronto S.E.

Equities

KLY

CA48349P1036

End-of-day quote Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- PTS -.--% Intraday chart for Kalytera Therapeutics Inc -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
KALYTERA THERAPEUTICS INC
Other Biotechnology & Medical Research
-.--%-.--% - - - 690K - - -
  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. KLY Stock
  5. Charts Kalytera Therapeutics Inc
  6. Relative Strength Chart